NASDAQ:AXGNAxoGen Stock Price, Forecast & News

AxoGen's stock was trading at $10.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXGN shares have increased by 7.4% and is now trading at $11.49. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AxoGen in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AxoGen.

AxoGen is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for AxoGen.

AxoGen, Inc (NASDAQ:AXGN) announced its quarterly earnings data on Wednesday, May, 6th. The medical equipment provider reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.04. The medical equipment provider earned $24.26 million during the quarter, compared to the consensus estimate of $24.30 million. AxoGen had a negative return on equity of 20.04% and a negative net margin of 25.84%. View AxoGen's earnings history.

AxoGen issued an update on its second quarter 2020 Pre-Market earnings guidance on Wednesday, July, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $21 million, compared to the consensus revenue estimate of $11.67 million.

5 Wall Street analysts have issued 12 month price targets for AxoGen's stock. Their forecasts range from $12.00 to $28.00. On average, they expect AxoGen's stock price to reach $19.25 in the next twelve months. This suggests a possible upside of 67.5% from the stock's current price. View analysts' price targets for AxoGen.

Headlines about AXGN stock have trended somewhat negative recently, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. AxoGen earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about AxoGen.

AxoGen saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 1,180,000 shares, a drop of 20.8% from the May 31st total of 1,490,000 shares. Based on an average trading volume of 581,300 shares, the short-interest ratio is presently 2.0 days. Currently, 3.3% of the company's shares are short sold. View AxoGen's Current Options Chain.

Some companies that are related to AxoGen include InMode (INMD), Zynex (ZYXI), Natus Medical (NTUS), BioLife Solutions (BLFS), TransMedics Group (TMDX), Viewray (VRAY), Stereotaxis (STXS), Semler Scientific (SMLR), Cutera (CUTR), BioSig Technologies (BSGM), Fonar (FONR), Soleno Therapeutics (SLNO), Edap Tms (EDAP), Fc Global Realty (FCRE) and electroCore (ECOR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AxoGen investors own include Intelsat (I), Corbus Pharmaceuticals (CRBP), Xilinx (XLNX), Bank of America (BAC), Exelixis (EXEL), Micron Technology (MU), Advanced Micro Devices (AMD), Crispr Therapeutics (CRSP), Sangamo Therapeutics (SGMO) and AMC Entertainment (AMC).

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

Shares of AXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AXGN stock can currently be purchased for approximately $11.49.

AxoGen has a market capitalization of $456.84 million and generates $106.71 million in revenue each year. The medical equipment provider earns $-29,140,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.

The official website for AxoGen is www.axogeninc.com.

AxoGen's mailing address is 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-462-6800 or via email at [email protected]